Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation

NCT04833712 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.

NCT NCT04833712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04833712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation
Lead sponsor
National and Kapodistrian University of Athens
Phase
Not applicable
Overall status
Unknown status
Start date
May 10, 2021
Completion date
August 30, 2022
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia, atrial fibrillation, cardiovascular diseases, heart arrhythmia